Depakote Anti-Epilepsy Drug and Severe Birth Defect Risks
Anti-Epilepsy Drug Risk Of Birth Defect. Spina bifida is a condition where the bones around the spine do not form correctly. The anti-epilepsy drug Depakote increases the risk of this birth defect. A lawsuit is filed on behalf of a boy born with this condition. Plaintiffs allege that Abbott, the manufacturer of Depakote, neglected to … [Read more...] about Depakote Anti-Epilepsy Drug and Severe Birth Defect Risks
Botox Maker Sues to Have Off-Label Marketing Rules Lifted
Botox Maker Off-Label Marketing. Allergan Inc. is claiming that rules forbidding it from distributing information about the off-label use of Botox wrinkle treatment and other drugs are a violation of its First Amendment right to free speech. According to The Wall Street Journal, the drug maker has filed suit against the Food & … [Read more...] about Botox Maker Sues to Have Off-Label Marketing Rules Lifted
Pfizer Obstructing Off-label Marketing Probe
Pfizer Off-label Marketing Probe. An investigation of Pfizer Inc. drug marketing efforts has resulted in charges being filed against a former Pfizer sales manager. The four count indictment alleges that the former Pfizer employee tried to obstruct an investigation into possible off-label marketing of some ‘Pfizer’ … [Read more...] about Pfizer Obstructing Off-label Marketing Probe
Bristol Myers Squibb to Pay $515M for Kickback
Bristol Myers Squibb to Pay $515 Million. Bristol Myers Squibb and its affiliate Apothecon, Inc. paid kickbacks to physicians for prescribing the company’s drugs and illegally promoted the off-label use of the anti-psychotic drug Abilify. Now, Bristol Myers Squibb has agreed to pay more than $500,000 to settle a civil … [Read more...] about Bristol Myers Squibb to Pay $515M for Kickback
